Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03929640 · ClinicalTrials.gov registry record · Phase 3
Management Of Pain After Cesarean Trial
A Phase 3 study, sponsored by Milton S. Hershey Medical Center.
- Terminated
- Registry status
- Phase 3
- Development phase
- 49
- Enrollment target
NCT03929640 is a Phase 3 study that was terminated before completion, run by Milton S. Hershey Medical Center. The registered enrollment target is 49 participants.
The verdict
NCT03929640, a Phase 3 study, was terminated before completion, sponsored by Milton S. Hershey Medical Center.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 49 participants
- Enrollment target
Study Summary
This is a double blinded randomized controlled trial to test the efficacy of a combination of acetaminophen and ibuprofen administered to patients on schedule compared to ibuprofen alone on the patient's reported pain score on the second post-operative day after Cesarean delivery. The investigators will also record opiate consumption and pain scores throughout the hospitalization of participants, and will survey patients at one and two weeks after surgery regarding opiate consumption and quality of life.
Interventions
- DRUG Placebo
- DRUG Acetaminophen
- DRUG Ibuprofen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2019-08-05 |
| Est. Completion | 2020-03-26 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03929640
The ClinicalTrials.gov registry entry for NCT03929640 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03929640 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03929640 about?
NCT03929640 is a clinical study titled "Management Of Pain After Cesarean Trial". This is a double blinded randomized controlled trial to test the efficacy of a combination of acetaminophen and ibuprofen administered to patients on schedule compared to ibuprofen alone on the patient's reported pain score on the second post-operative day after Cesarean delivery. The investigators ...
What is the current status of trial NCT03929640?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 49 participants. The study started on 2019-08-05. Estimated completion is 2020-03-26.
What interventions are being tested in trial NCT03929640?
The interventions under investigation include: Placebo (DRUG), Acetaminophen (DRUG), Ibuprofen (DRUG).
Who is sponsoring clinical trial NCT03929640?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.